Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

SAGE THERAPEUTICS, INC.

(SAGE)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SAGE THERAPEUTICS, INC.
29/11Sage Therapeutics to Host Sage FutureCast Webcast
24/11Sage Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confer..
11/11Sage Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
02/11Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin..
02/11Sage Therapeutics Reports Widened Q3 Loss as Revenue Drops
02/11SAGE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition an..
02/11Sage Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
02/11Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipelin..
20/10SAGE THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Tuesday, November 2,..
20/10SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z..
19/10SAGE THERAPEUTICS : and Biogen Announce Plans to Submit a New Drug Application (NDA) for Z..
19/10SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
19/10SAGE THERAPEUTICS : Biogen Submit Depression Drug Zuranolone New Drug Application to FDA
19/10Sage Therapeutics, Biogen to Seek FDA Approval of Zuranolone in 2nd Half of 2022
04/10SAGE THERAPEUTICS : and Biogen Announce Consistent Clinically Meaningful Data for Zuranolo..
01/10SAGE THERAPEUTICS : Launches SageCitizen Social Impact Initiative
21/09SAGE THERAPEUTICS : Names Chris Benecchi as Chief Commercial Officer
21/09SAGE THERAPEUTICS : Appoints Chris Benecchi as Chief Commercial Officer
21/09Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
16/09SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
15/09SAGE THERAPEUTICS : Receives US FDA Fast Track Designation for Potential Huntington's Dise..
15/09SAGE THERAPEUTICS : Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
15/09Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Hun..
15/09Sage Therapeutics Gets Fast-Track Designation for Huntington's Disease Treatment
02/09SAGE THERAPEUTICS : to Present at the Morgan Stanley Global Healthcare Conference
23/08AXSOME THERAPEUTICS : says U.S. FDA asks for no extra data for depression drug, shares sur..
11/08SAGE THERAPEUTICS : Insider Makes Significant Stock buy in Sage Therapeutics (SAGE) Shares..
09/08INSIDER TRENDS : Sage Therapeutics Insider 90-Day Buying Trend Continued with Purchase
04/08SAGE THERAPEUTICS : to Present at Upcoming August Investor Conferences
03/08SAGE THERAPEUTICS : Narrows Q2 Loss as Revenue Grows
03/08SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
03/08Sage Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, ..
03/08SAGE THERAPEUTICS : Company announces REDWOOD and RAINFOREST Studies not expected to be re..
03/08SAGE THERAPEUTICS : Announces Second Quarter 2021 Financial Results and Highlights Pipelin..
27/07MF ANALISI : quando la scienza si scontra con i mercati
20/07SAGE THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Tuesday, August 3, ..
09/07SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
08/07SAGE THERAPEUTICS : to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
25/06SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 2500 Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell Small Cap Comp Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 3000 Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell Midcap Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 3000E Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM : SAGE) dropped from Russell 1000 Growth Index
24/06SAGE THERAPEUTICS : to Participate in SVB Leerink's 3rd Annual CNS Forum
19/06SAGE THERAPEUTICS : Insiders at Sage Therapeutics (SAGE) Make Significant purchases of Sto..
17/06Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone f..
17/06INSIDER TRENDS : Insider Purchase Continues Sage Therapeutics Positive Trend
17/06INSIDER TRENDS : Insider Purchase of Sage Therapeutics Stock Extends 90-Day Positive Trend
17/06INSIDER TRENDS : Sage Therapeutics Insider Awarded Stock, Exercises Derivative Security, P..
17/06NORTH AMERICAN MORNING BRIEFING : Markets Slip and -3-
16/06SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone an..
15/06Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise
15/06SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday
15/06Les valeurs à suivre mardi 15 juin 2021 à Wall Street -
15/06BIOGEN : non pour la choroïdérémie, oui pour la dépression
15/06SAGE THERAPEUTICS : to Host Conference Call
15/06BIOGEN : données de phase III positives pour Zuranolone
15/06SAGE THERAPEUTICS : Biogen Say Zuranolone Study Meets Primary Endpoint in Patients With Ma..
15/06SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, a..
15/06SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
15/06SAGE THERAPEUTICS : depression drug meets late-stage study goal
15/06Sage, Biogen's Zuranolone Meets Primary Endpoint in Phase 3 Trial
10/06SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
20/05SAGE THERAPEUTICS : Joins MTV Entertainment Group and More Than 1,300 Leading Organization..
13/05SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth
13/05SAGE THERAPEUTICS, INC. TO HOST SAGE : SAGE-718 In Depth
04/05SAGE THERAPEUTICS : Company on-track to initiate placebo-controlled Phase 2 trial with SAG..
04/05SAGE THERAPEUTICS : Q1 Net Loss Narrows
04/05SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
04/05SAGE THERAPEUTICS : Announces First Quarter 2021 Financial Results and Highlights Pipeline..
04/05Sage Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
28/04SAGE THERAPEUTICS : to Present at Upcoming May Investor Conferences
20/04SAGE THERAPEUTICS : to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
1  2  3  4  5  6  7Volgende
Volgende evenement op SAGE THERAPEUTICS, INC.
23/02/22